(ZLAB) Zai Lab - Performance 102.3% in 12m
ZLAB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-35.62%
#52 in Peer-Group
Rel. Strength
93.57%
#478 in Stock-Universe
Total Return 12m
102.26%
#14 in Peer-Group
Total Return 5y
-56.88%
#67 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 43.03 USD |
| 52 Week Low | 16.25 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 37.43 |
| Buy/Sell Signal +-5 | -1.46 |
| Support / Resistance | Levels |
|---|---|
| Support | 33.5, 30.8, 26.9, 24.4, 20.0, 18.0 |
| Resistance |
12m Total Return: ZLAB (102.3%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ZLAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ZLAB
| Total Return (including Dividends) | ZLAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 12.12% | 2.09% | 4.55% |
| 3 Months | -3.24% | 2.27% | 10.78% |
| 12 Months | 102.26% | -10.84% | 14.71% |
| 5 Years | -56.88% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | ZLAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.8% | 18.8% | 79.2% |
| 3 Months | 49.7% | 71.5% | 92.9% |
| 12 Months | 84.8% | -84.3% | 44.2% |
| 5 Years | -81.1% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.50 | 9.83% | 7.24% |
| 3 Month | %th45.00 | -5.38% | -12.65% |
| 12 Month | %th93.50 | 126.84% | 76.32% |
| 5 Years | %th66.50 | -41.54% | -79.71% |
FAQs
Does Zai Lab (ZLAB) outperform the market?
Yes,
over the last 12 months ZLAB made 102.26%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months ZLAB made -3.24%, while XBI made 2.27%.
Performance Comparison ZLAB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ZLAB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.8% | 7.6% | 27.5% | 88% |
| US NASDAQ 100 | QQQ | -6.7% | 6.6% | 25.3% | 87% |
| German DAX 40 | DAX | -5.7% | 12.1% | 14.5% | 72% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -5.5% | 8% | 29.5% | 85% |
| Hongkong Hang Seng | HSI | -5.4% | 6.3% | 11.7% | 67% |
| India NIFTY 50 | INDA | -5.4% | 10% | 27.7% | 102% |
| Brasil Bovespa | EWZ | -7.2% | 4.4% | 3% | 89% |
ZLAB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -7.4% | 5.4% | 20.8% | 74% |
| Consumer Discretionary | XLY | -4.3% | 10.5% | 36.2% | 82% |
| Consumer Staples | XLP | -2.4% | 13.8% | 29.3% | 93% |
| Energy | XLE | -1.5% | 8.6% | 32.9% | 106% |
| Financial | XLF | -5.9% | 9% | 24.4% | 73% |
| Health Care | XLV | -4.9% | 10.1% | 34.7% | 108% |
| Industrial | XLI | -5.4% | 8.4% | 20.9% | 78% |
| Materials | XLB | -3.9% | 10.5% | 28.1% | 99% |
| Real Estate | XLRE | -1.4% | 12.1% | 30.1% | 90% |
| Technology | XLK | -7.2% | 3.2% | 24.2% | 90% |
| Utilities | XLU | -3.4% | 12.1% | 24.1% | 78% |
| Aerospace & Defense | XAR | -7.8% | 2.3% | 6.1% | 50% |
| Biotech | XBI | -3.7% | 10% | 41.4% | 113% |
| Homebuilder | XHB | -4.1% | 6% | 38.7% | 101% |
| Retail | XRT | -2.8% | 10.7% | 36.2% | 96% |
ZLAB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.4% | 7.00% | 36.8% | 113% |
| Natural Gas | UNG | 6.4% | 21.6% | 42.6% | 110% |
| Gold | GLD | -0.9% | 14.3% | 7.6% | 61% |
| Silver | SLV | -2.4% | 8.3% | 8.9% | 80% |
| Copper | CPER | -6.1% | 7.9% | 7.8% | 87% |
ZLAB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -4.6% | 8.5% | 30.7% | 100% |
| iShares High Yield Corp. Bond | HYG | -3.8% | 10.3% | 28.5% | 91% |